RO92607A - Procedeu pentru prepararea unor derivati de dihidropiridazinona - Google Patents

Procedeu pentru prepararea unor derivati de dihidropiridazinona

Info

Publication number
RO92607A
RO92607A RO85120090A RO12009085A RO92607A RO 92607 A RO92607 A RO 92607A RO 85120090 A RO85120090 A RO 85120090A RO 12009085 A RO12009085 A RO 12009085A RO 92607 A RO92607 A RO 92607A
Authority
RO
Romania
Prior art keywords
preparation
compounds
formula
dihydropyridazinone derivatives
dihydropyridazinone
Prior art date
Application number
RO85120090A
Other languages
English (en)
French (fr)
Inventor
Robert A Slater
Original Assignee
Smith Kline & French Laboratories Ltd,Gb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd,Gb filed Critical Smith Kline & French Laboratories Ltd,Gb
Publication of RO92607A publication Critical patent/RO92607A/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/28—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of guanidine groups bound to cyano groups, e.g. cyanoguanidines, dicyandiamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
RO85120090A 1984-01-13 1985-09-12 Procedeu pentru prepararea unor derivati de dihidropiridazinona RO92607A (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848400863A GB8400863D0 (en) 1984-01-13 1984-01-13 Chemical compounds

Publications (1)

Publication Number Publication Date
RO92607A true RO92607A (ro) 1987-11-30

Family

ID=10554924

Family Applications (1)

Application Number Title Priority Date Filing Date
RO85120090A RO92607A (ro) 1984-01-13 1985-09-12 Procedeu pentru prepararea unor derivati de dihidropiridazinona

Country Status (31)

Country Link
US (1) US4654342A (ro)
EP (1) EP0150937B1 (ro)
JP (3) JPS60158181A (ro)
KR (1) KR920006781B1 (ro)
CN (1) CN85101722A (ro)
AT (1) ATE37179T1 (ro)
AU (1) AU572252B2 (ro)
CA (2) CA1251209A (ro)
CS (1) CS248731B2 (ro)
DD (1) DD231350A5 (ro)
DE (1) DE3564941D1 (ro)
DK (1) DK162519C (ro)
ES (3) ES8607949A1 (ro)
FI (1) FI850140L (ro)
GB (1) GB8400863D0 (ro)
GR (1) GR850068B (ro)
HU (1) HU193591B (ro)
IE (1) IE57969B1 (ro)
IL (1) IL74031A (ro)
JO (1) JO1351B1 (ro)
MY (1) MY100124A (ro)
NO (1) NO850129L (ro)
NZ (1) NZ210816A (ro)
PH (1) PH22136A (ro)
PL (1) PL147123B1 (ro)
PT (1) PT79819B (ro)
RO (1) RO92607A (ro)
SU (1) SU1396963A3 (ro)
WO (1) WO1985003076A1 (ro)
ZA (1) ZA85251B (ro)
ZW (1) ZW385A1 (ro)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1251448A (en) * 1985-03-27 1989-03-21 William J. Coates Pyridazinone derivatives
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
GB8722776D0 (en) * 1987-09-28 1987-11-04 Smith Kline French Lab Chemical compounds
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
CA2475454A1 (en) * 2001-02-27 2002-09-06 Mitokor Aryl-n-cyanoguanidines and methods related thereto
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004011512B4 (de) * 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmazeutische Zubereitung enthaltend Pimobendan
US8980894B2 (en) * 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) * 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
BRPI0618643A2 (pt) 2005-11-09 2011-09-06 Combinatorx Inc composição compreendendo um par de fármacos, composição compreendendo um corticosteróide e um imunossupressor dependente de imunofilina não-esteróide, kits e uso
HUE033546T2 (hu) * 2005-11-14 2017-12-28 Boehringer Ingelheim Vetmedica Gmbh Pimobendán alkalmazása aszimptómás (rejtett) szívelégtelenség kezelésére
EP1920785A1 (en) * 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
EP2810951B1 (en) 2008-06-04 2017-03-15 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
EP2702986A1 (en) 2008-11-25 2014-03-05 Boehringer Ingelheim Vetmedica GmbH Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN107090016A (zh) 2011-03-01 2017-08-25 辛纳吉制药公司 制备鸟苷酸环化酶c激动剂的方法
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
ES2924478T3 (es) 2012-03-15 2022-10-07 Boehringer Ingelheim Vetmedica Gmbh Formulación de comprimidos farmacéuticos para el sector médico veterinario, método de producción y uso de los mismos
EP3718557A3 (en) 2013-02-25 2020-10-21 Bausch Health Ireland Limited Guanylate cyclase receptor agonist sp-333 for use in colonic cleansing
WO2014151200A2 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
KR102272746B1 (ko) 2013-06-05 2021-07-08 보슈 헬스 아일랜드 리미티드 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법
EP3021832B9 (en) 2013-07-19 2023-03-15 Boehringer Ingelheim Vetmedica GmbH Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
EP3030252B1 (en) 2013-08-09 2018-11-07 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
ES2883448T3 (es) 2013-12-04 2021-12-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmacéuticas mejoradas de pimobendán
CN104987310A (zh) * 2015-06-03 2015-10-21 青岛农业大学 左西孟旦的合成工艺
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN110117257B (zh) * 2018-02-05 2022-12-06 安徽省新星药物开发有限责任公司 一种含胍基的p2y12受体拮抗剂、制备方法及其用途
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3822260A (en) * 1970-10-09 1974-07-02 American Cyanamid Co 6-(cyanophenyl)-4,5-dihydro-3(2h)-pyridazinones
BE791539A (fr) * 1971-11-19 1973-05-17 Basf Ag Dihydropyridazones, leur preparation et leurs utilisations therapeutiques
EP0030835B1 (en) * 1979-12-05 1983-05-11 Morishita Pharmaceutical Co. Ltd. Derivatives of 2-substituted-6-phenyl-3(2h)pyridazinone, their production and pharmaceutical compositions containing them
DE3263497D1 (en) * 1981-03-04 1985-06-20 Ciba Geigy Ag Pyridazinones, method for their preparation, pharmaceutical compositions containing these compounds and their use
JPS58113180A (ja) * 1981-12-28 1983-07-05 Mitsui Toatsu Chem Inc ピリダジノン誘導体
DE3204375C2 (de) * 1982-02-09 1983-12-01 J. Rettenmaier & Söhne GmbH + Co, 7091 Holzmühle Verfahren zur Herabsetzung der Saugfähigkeit von Holz
JPS58140076A (ja) * 1982-02-09 1983-08-19 Mitsubishi Chem Ind Ltd ピリダジノン誘導体又はその塩類
DE3302021A1 (de) * 1983-01-22 1984-07-26 Basf Ag, 6700 Ludwigshafen 6-aryl-4,5-dihydro-3(2h)-pyridazinone, ihre herstellung und verwendung
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones

Also Published As

Publication number Publication date
AU3761185A (en) 1985-07-18
KR920006781B1 (ko) 1992-08-17
US4654342A (en) 1987-03-31
ZA85251B (en) 1986-08-27
ES8706645A1 (es) 1987-07-01
JPS63313775A (ja) 1988-12-21
ES554965A0 (es) 1987-07-01
PH22136A (en) 1988-06-01
DK162519C (da) 1992-03-30
IE57969B1 (en) 1993-06-02
CS248731B2 (en) 1987-02-12
SU1396963A3 (ru) 1988-05-15
FI850140A0 (fi) 1985-01-11
AU572252B2 (en) 1988-05-05
ES539446A0 (es) 1986-06-01
PT79819A (en) 1985-02-01
CA1260471C (ro) 1989-09-26
EP0150937A2 (en) 1985-08-07
NO850129L (no) 1985-07-15
ES8607949A1 (es) 1986-06-01
EP0150937A3 (en) 1985-08-21
IL74031A (en) 1988-07-31
NZ210816A (en) 1987-06-30
DD231350A5 (de) 1985-12-24
ES8703846A1 (es) 1987-03-01
IL74031A0 (en) 1985-04-30
DE3564941D1 (en) 1988-10-20
ATE37179T1 (de) 1988-09-15
JPS63313776A (ja) 1988-12-21
DK162519B (da) 1991-11-11
WO1985003076A1 (en) 1985-07-18
GB8400863D0 (en) 1984-02-15
EP0150937B1 (en) 1988-09-14
JPS60158181A (ja) 1985-08-19
CN85101722A (zh) 1987-01-31
FI850140L (fi) 1985-07-14
MY100124A (en) 1989-12-18
DK9185A (da) 1985-07-14
ZW385A1 (en) 1985-08-07
GR850068B (ro) 1985-05-03
DK9185D0 (da) 1985-01-08
PT79819B (en) 1987-01-07
KR850005417A (ko) 1985-08-26
CA1251209A (en) 1989-03-14
PL147123B1 (en) 1989-04-29
ES549629A0 (es) 1987-03-01
IE850069L (en) 1985-07-13
JO1351B1 (en) 1986-11-30
CA1260471A (en) 1989-09-26
PL251516A1 (en) 1985-12-17
HU193591B (en) 1987-11-30
HUT37128A (en) 1985-11-28

Similar Documents

Publication Publication Date Title
RO92607A (ro) Procedeu pentru prepararea unor derivati de dihidropiridazinona
ES524680A0 (es) Procedimiento de obtencion de nuevos compuestos derivados de la difenil-metilen-etilamina.
PT84760B (pt) Processo de preparacao de derivados de tiadiazinona, de seus intermediarios e de composicoes farmaceuticas
IL79280A (en) 4-(6-oxo-dihydro or tetrahydropyridazin-3-yl)benzene derivatives,their preparation and pharmaceutical compositions containing them
FR2626279B1 (fr) Nouveaux derives de l'indolo(3,2,1-de)(1,4)-oxazino(2,3,4-ij)(1,5) naphthyridine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
DK1264836T3 (da) Fremgangsmåde til fremstilling af indolopyrrolocarbaxolderivater